Twist Bioscience Corporation TWST Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from Twist Bioscience Corporation’s reported figures.
Based on trailing twelve months.
The official record: Twist Bioscience Corporation’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Twist Bioscience Corporation's return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Twist Bioscience Corporation's return on equity?
- Twist Bioscience Corporation (TWST) reported return on equity of -18.2% in Q1 2026.
- How has Twist Bioscience Corporation's return on equity changed year-over-year?
- Twist Bioscience Corporation's return on equity increased by 52.5% year-over-year, from -38.2% to -18.2%.
- What is the long-term trend for Twist Bioscience Corporation's return on equity?
- Over 5 years (2020 to 2025), Twist Bioscience Corporation's return on equity has grown at a -22.1% compound annual growth rate (CAGR), from -57.3% to -16.4%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.